2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow MDD: new trials by email Literature Review of MDD trials Research Report on MDD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD) Xanamem™, Placebo - Major Depressive Disorder, MDD | Phase 2 | Completed | Actinogen Medical | 167 | 2022-11-28 | 2025-01-22 |
| Effect of Magnesium Supplementation in Selective Serotonin Reuptake Inhibitors Treated Major Depressive Disorder Patients Magnesium Glycinate tablet 200mg, Placebo tablet 200mg - MDD | Phase 2 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 90 | 2021-03-18 | 2022-03-21 |
Cognitive Dysfunction (1) · Depressive Disorder, Major (1)
Cognition Disorders (1) · Depressive Disorder (1) · Mental Disorders (1) · Mood Disorders (1) · Neurocognitive Disorders (1)
UE2343 (1) · magnesium diglycinate (1)
Actinogen Medical (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1)
Australia (1) · Bangladesh (1) · United Kingdom (1)